Free Trial

Kiniksa Pharmaceuticals (KNSA) SEC Filings & 10K Form

Kiniksa Pharmaceuticals logo
$20.36 -1.40 (-6.43%)
Closing price 04:00 PM Eastern
Extended Trading
$20.36 0.00 (0.00%)
As of 06:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Kiniksa Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/03/2025
4:06 PM
Kiniksa Pharmaceuticals (Issuer)
Moat Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
3:52 PM
Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
3:35 PM
Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:48 PM
Kiniksa Pharmaceuticals (Issuer)
Paolini John F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:49 PM
Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:50 PM
Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:51 PM
Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:52 PM
Kiniksa Pharmaceuticals (Issuer)
Moat Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:53 PM
Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
4:29 PM
Kiniksa Pharmaceuticals (Subject)
Ragosa Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/14/2025
3:37 PM
Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
3:38 PM
Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
3:47 PM
Kiniksa Pharmaceuticals (Subject)
Megna Michael R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/12/2025
3:37 PM
Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:13 PM
Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/25/2025
3:31 PM
Kiniksa Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/25/2025
3:15 PM
Kiniksa Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2025
6:31 AM
Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
2:45 PM
Fairmount Funds Management LLC (Filed by)
Kiniksa Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/10/2025
4:37 PM
Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2025
3:42 PM
Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:27 PM
Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
6:34 AM
Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
3:45 PM
Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
4:17 PM
Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
3:34 PM
Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
6:14 PM
Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
4:25 PM
Kiniksa Pharmaceuticals (Subject)
Ragosa Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2024
4:13 PM
Kiniksa Pharmaceuticals (Subject)
Megna Michael R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/18/2024
4:50 PM
Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
3:32 PM
HHLR ADVISORS, LTD. (Filed by)
Kiniksa Pharmaceuticals (Subject)
Form SC 13G/A
11/13/2024
3:30 PM
Kiniksa Pharmaceuticals (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13G/A
11/06/2024
3:11 PM
Kiniksa Pharmaceuticals (Subject)
Patel Sanj K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/29/2024
3:14 PM
Kiniksa Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/29/2024
6:31 AM
Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2024
3:11 PM
BlackRock, Inc. (Filed by)
Kiniksa Pharmaceuticals (Subject)
Form SC 13G
10/17/2024
3:35 PM
Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
3:57 PM
Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/08/2024
4:29 PM
BAKER BROS. ADVISORS LP (Filed by)
Kiniksa Pharmaceuticals (Subject)
Form SC 13D/A
10/08/2024
4:08 PM
Boyd Meta Cantey (Reporting)
Kiniksa Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/08/2024
3:40 PM
Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump to unlock 15-figure fortune for America (May 3rd) ? (Ad)

We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America. Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking. And he believes Trump could soon release this frozen asset to the public.

But something even more spectacular is bound to happen. And those who know what to expect could make
10/08/2024
3:14 PM
667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Kiniksa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2024
3:39 PM
Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
4:02 PM
Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
7:57 PM
Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
7:51 PM
Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
7:52 PM
Kiniksa Pharmaceuticals (Issuer)
Paolini John F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
7:53 PM
Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
7:55 PM
Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
7:42 PM
Kiniksa Pharmaceuticals (Issuer)
Moat Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
4:16 PM
Kiniksa Pharmaceuticals (Subject)
Paolini John F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/03/2024
4:17 PM
Kiniksa Pharmaceuticals (Subject)
Moat Ross (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/29/2024
3:36 PM
Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
4:17 PM
Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/25/2024
3:31 PM
Kiniksa Pharmaceuticals (Issuer)
Paolini John F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2024
3:32 PM
Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2024
3:33 PM
Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2024
3:10 PM
Kiniksa Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/23/2024
6:54 AM
Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/04/2024
11:15 PM
Kiniksa Pharmaceuticals (Filer)
Form EFFECT
07/04/2024
11:15 PM
Kiniksa Pharmaceuticals (Filer)
Form EFFECT
06/30/2024
11:15 PM
Kiniksa Pharmaceuticals (Filer)
Form EFFECT
06/28/2024
4:29 PM
Kiniksa Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/28/2024
4:30 PM
Kiniksa Pharmaceuticals (Filer)
Form 15-15D
06/28/2024
4:22 PM
Kiniksa Pharmaceuticals (Filer)
Form POS AM
06/28/2024
4:22 PM
Kiniksa Pharmaceuticals (Filer)
Form S-8 POS
06/28/2024
4:23 PM
Kiniksa Pharmaceuticals (Filer)
Form S-8 POS
06/28/2024
4:23 PM
Kiniksa Pharmaceuticals (Filer)
Form S-8 POS
06/28/2024
4:24 PM
Kiniksa Pharmaceuticals (Filer)
Form S-8 POS
06/28/2024
4:24 PM
Kiniksa Pharmaceuticals (Filer)
Form S-8 POS
06/28/2024
4:25 PM
Kiniksa Pharmaceuticals (Filer)
Form S-8 POS
06/27/2024
8:34 PM
Kiniksa Pharmaceuticals (Filer)
Form POS AM
06/25/2024
3:30 PM
Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
3:27 PM
Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
3:35 PM
Kiniksa Pharmaceuticals (Issuer)
Quart Barry D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:36 PM
Kiniksa Pharmaceuticals (Issuer)
Popovits Kimberly J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:37 PM
Kiniksa Pharmaceuticals (Issuer)
McCain Tracey L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:39 PM
Kiniksa Pharmaceuticals (Issuer)
Malley Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:40 PM
Kiniksa Pharmaceuticals (Issuer)
Levy Richard S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:41 PM
Cole G Bradley (Reporting)
Kiniksa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:27 PM
Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2024
4:19 PM
Kiniksa Pharmaceuticals (Filer)
Form DEFA14A
05/07/2024
3:46 PM
Kiniksa Pharmaceuticals (Issuer)
Levy Richard S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
3:35 PM
Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
3:36 PM
Kiniksa Pharmaceuticals (Filer)
Form DEF 14A
04/23/2024
3:41 PM
Kiniksa Pharmaceuticals (Filer)
Form ARS
04/23/2024
3:43 PM
Kiniksa Pharmaceuticals (Filer)
Form DEFA14A
04/23/2024
3:46 PM
Kiniksa Pharmaceuticals (Filer)
Form DEFA14A
04/23/2024
6:34 AM
Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
4:00 PM
Kiniksa Pharmaceuticals (Filer)
Form PRE 14A
04/08/2024
4:20 PM
Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Feds Just Admitted It—They Can Take Your Cash (Ad)

The Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money isn't legally yours. Now, think your savings are safe? Think again.

Click here to get the 3 secret strategies you can put in place starting today
04/08/2024
4:21 PM
Kiniksa Pharmaceuticals (Issuer)
Paolini John F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
4:22 PM
Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
4:17 PM
Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
4:18 PM
Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
4:19 PM
Kiniksa Pharmaceuticals (Issuer)
Moat Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2024
11:21 AM
BlackRock Inc. (Filed by)
Kiniksa Pharmaceuticals (Subject)
Form SC 13G/A
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:KNSA) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners